RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hyundai Bioscience Co - Stock

Hyundai Bioscience Co ROCE 2024

Hyundai Bioscience Co ROCE

0

Ticker

048410.KQ

ISIN

KR7048410005

In 2024, Hyundai Bioscience Co's return on capital employed (ROCE) was 0, a -100% increase from the -0.45 ROCE in the previous year.

Hyundai Bioscience Co Aktienanalyse

What does Hyundai Bioscience Co do?

Hyundai Bioscience Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Hyundai Bioscience Co's Return on Capital Employed (ROCE)

Hyundai Bioscience Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Hyundai Bioscience Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Hyundai Bioscience Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Hyundai Bioscience Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Hyundai Bioscience Co Stock

What is the ROCE (Return on Capital Employed) of Hyundai Bioscience Co this year?

The ROCE of Hyundai Bioscience Co is 0 undefined this year.

How has the ROCE (Return on Capital Employed) of Hyundai Bioscience Co developed compared to the previous year?

The ROCE of Hyundai Bioscience Co has increased by -100% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Hyundai Bioscience Co?

A high Return on Capital Employed (ROCE) indicates that Hyundai Bioscience Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Hyundai Bioscience Co?

A low ROCE (Return on Capital Employed) can indicate that Hyundai Bioscience Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Hyundai Bioscience Co impact the company?

An increase in the ROCE of Hyundai Bioscience Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Hyundai Bioscience Co affect the company?

A decrease in ROCE of Hyundai Bioscience Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Hyundai Bioscience Co?

Some factors that can affect Hyundai Bioscience Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Hyundai Bioscience Co so important for investors?

The ROCE of Hyundai Bioscience Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Hyundai Bioscience Co take to improve the ROCE?

To improve the ROCE, Hyundai Bioscience Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Hyundai Bioscience Co pay?

Over the past 12 months, Hyundai Bioscience Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hyundai Bioscience Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Hyundai Bioscience Co?

The current dividend yield of Hyundai Bioscience Co is .

When does Hyundai Bioscience Co pay dividends?

Hyundai Bioscience Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hyundai Bioscience Co?

Hyundai Bioscience Co paid dividends every year for the past 0 years.

What is the dividend of Hyundai Bioscience Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hyundai Bioscience Co located?

Hyundai Bioscience Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Hyundai Bioscience Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hyundai Bioscience Co from 4/13/2004 amounting to 50 KRW, you needed to have the stock in your portfolio before the ex-date on 12/29/2003.

When did Hyundai Bioscience Co pay the last dividend?

The last dividend was paid out on 4/13/2004.

What was the dividend of Hyundai Bioscience Co in the year 2023?

In the year 2023, Hyundai Bioscience Co distributed 0 KRW as dividends.

In which currency does Hyundai Bioscience Co pay out the dividend?

The dividends of Hyundai Bioscience Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hyundai Bioscience Co

Our stock analysis for Hyundai Bioscience Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hyundai Bioscience Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.